Major bleeding: management and risk reduction in acute coronary syndromes

Author： Cavender Matthew A   Rao Sunil V   Ohman E Magnus  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.11, 2008-08, pp. : 1869-1883

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bleeding and Acute Coronary Syndromes: Defining, Predicting, and Managing Risk and Outcomes

By  

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1831-1835

Bentham Science Publishers

Access to resources Recommend Favorite

Assess risk in acute coronary syndromes

By  

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Ranolazine dose not reduce the risk of major cardiovascular events in patients with acute coronary syndromes

By  

Inpharma, Vol. 1, Iss. 1586, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Review of ticagrelor in the management of acute coronary syndromes

By Burgess Sonya   Mallard Trevor A   Juergens Craig P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1315-1325

Informa Healthcare

Access to resources Recommend Favorite

The role of antiplatelet therapy in the management of acute coronary syndromes

By Volturo Gregory A   Mazzola Jennifer L   Przylenk Karin  

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 541-556

Informa Healthcare

Access to resources Recommend Favorite